DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

NewLink Genetics Q4 EPS $(0.22) Beats $(0.28) Estimate, Sales $433K Beat $250K Estimate

NewLink Genetics (NASDAQ:NLNK) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.28) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.28) per share from

Benzinga · 02/28/2020 14:03

NewLink Genetics (NASDAQ:NLNK) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.28) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $433 thousand which beat the analyst consensus estimate of $250 thousand by 73.20 percent. This is a 114.36 percent increase over sales of $202 thousand the same period last year.